Drug-induced photosensitivity

Dermatologic Clinics

Volumn 32, Issue 3, 2014, Pages 363-368

  Dawe, Robert S ^a   Ibbotson, Sally H ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Drug; Photoallergy; Photosensitivity; Phototoxicity; Xenobiotic

Indexed keywords

PORPHYRIN;

CLINICAL FEATURE; DRUG INDUCED DISEASE; HUMAN; INCIDENCE; LABORATORY TEST; PATHOPHYSIOLOGY; PHOTOALLERGY; PHOTOBIOLOGY; PHOTOPATCH TEST; PHOTOSENSITIVITY DISORDER; PHOTOSENSITIZATION; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SUNBURN; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; CHEMICALLY INDUCED; DRUG EFFECTS; HEALTH; PATCH TEST; PHOTOSENSITIVITY DISORDERS; RADIATION RESPONSE; SKIN;

GLOBAL HEALTH; HUMANS; INCIDENCE; PATCH TESTS; PHOTOSENSITIVITY DISORDERS; SKIN;

EID: 84901642389     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2014.03.014     Document Type: Review

References (34)

1. Ferguson J. Photosensitivity due to drugs. Photodermatol Photoimmunol Photomed 2002, 18:262-269.
2. Urbach F. Phototoxicity and possible enhancement of photocarcinogenesis by fluorinated quinolone antibiotics. J Photochem Photobiol B 1997, 37:169-170.
3. O'Gorman S.M., Murphy G.M. Photosensitizing medications and photocarcinogenesis. Photodermatol Photoimmunol Photomed 2014, 30:8-14.
4. Johnson B.E., Gibbs N.K., Ferguson J. Quinolone antibiotic with potential to photosensitize skin tumorigenesis. J Photochem Photobiol B 1997, 37:171-173.
5. Lindelof B., Sigurgeirsson B., Tegner E., et al. PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 1999, 141:108-112.
6. Stern R.S., PUVA Follow-Up Study The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol 2012, 66:553-562.
7. Siiskonen S.J., Koomen E.R., Visser L.E., et al. Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma. Eur J Clin Pharmacol 2013, 69:1437-1444.
8. de Vries E., Trakatelli M., Kalabalikis D., et al. Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br J Dermatol 2012, 167(Suppl 2):1-13.
9. Epaulard O., Leccia M.T., Blanche S., et al. Phototoxicity and photocarcinogenesis associated with voriconazole. Med Mal Infect 2011, 41:639-645.
10. Chapman P.B., Hauschild A., Robert C., et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011, 364:2507-2516.
11. Ferguson J., Johnson B.E. Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies. Br J Dermatol 1990, 123:9-20.
12. European Multicentre Photopatch Test Study (EMCPPTS) Taskforce A European multicentre photopatch test study. Br J Dermatol 2012, 166:1002-1009.
13. Jindal N., Sharma N.L., Mahajan V.K., et al. Evaluation of photopatch test allergens for Indian patients of photodermatitis: preliminary results. Indian J Dermatol Venereol Leprol 2011, 77:148-155.
14. Chaabane H., Masmoudi A., Amouri M., et al. Cutaneous adverse drug reaction: prospective study of 118 cases. Tunis Med 2013, 91:514-520. [in French].
15. Fotiades J., Soter N.A., Lim H.W. Results of evaluation of 203 patients for photosensitivity in a 7.3-year period. J Am Acad Dermatol 1995, 33:597-602.
16. Wong S.N., Khoo L.S. Analysis of photodermatoses seen in a predominantly Asian population at a photodermatology clinic in Singapore. Photodermatol Photoimmunol Photomed 2005, 21:40-44.
17. Wadhwani A.R., Sharma V.K., Ramam M., et al. A clinical study of the spectrum of photodermatoses in dark-skinned populations. Clin Exp Dermatol 2013, 38:823-829.
18. Frain-Bell W. Cutaneous photobiology 1985, 125-152. Oxford University Press, Oxford (United Kingdom).
19. Tolland J.P., Murphy B.P., Boyle J., et al. Ciprofloxacin-induced phototoxicity in an adult cystic fibrosis population. Photodermatol Photoimmunol Photomed 2012, 28:258-260.
20. Ibbotson S.H., Farr P.M. The time-course of psoralen ultraviolet A (PUVA) erythema. J Invest Dermatol 1999, 113:346-350.
21. Man I., Dawe R.S., Ferguson J., et al. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B. Photochem Photobiol 2003, 78:55-60.
22. Man I., McKinlay J., Dawe R.S., et al. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen. J Am Acad Dermatol 2003, 49:59-64.
23. O'Reilly F.M., McKenna D., Murphy G.M. Is monochromatic irradiation testing useful in the differentiation of drug-induced photosensitivity from chronic actinic dermatitis?. Clin Exp Dermatol 1999, 24:118-121.
24. Kerr A., Shareef M., Dawe R., et al. Photopatch testing negative in systemic quinine phototoxicity. Photodermatol Photoimmunol Photomed 2010, 26:151-152.
25. Beattie P.E., Traynor N.J., Woods J.A., et al. Can a positive photopatch test be elicited by subclinical irritancy or allergy plus suberythemal UV exposure?. Contact Dermatitis 2004, 51:235-240.
26. Ferguson J., Dawe R. Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin. J Antimicrob Chemother 1997, 40(Suppl A):93-98.
27. Dawe R.S., Ibbotson S.H., Sanderson J.B., et al. A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity. Br J Dermatol 2003, 149:1232-1241.
28. Man I., Murphy J., Ferguson J. Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers. J Antimicrob Chemother 1999, 43(Suppl B):77-82.
29. Cameron H., Dawe R.S. Photosensitizing drugs may lower the narrow-band ultraviolet B (TL-01) minimal erythema dose. Br J Dermatol 2000, 142:389-390.
30. Stern R.S., Kleinerman R.A., Parrish J.A., et al. Phototoxic reactions to photoactive drugs in patients treated with PUVA. Arch Dermatol 1980, 116:1269-1271.
31. Dawe R.S. Ultraviolet A1 phototherapy. Br J Dermatol 2003, 148:626-637.
32. Kerr A.C., Ferguson J., Attili S.K., et al. Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report. Clin Exp Dermatol 2012, 37:219-226.
33. Beattie P.E., Dawe R.S., Traynor N.J., et al. Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?. Br J Dermatol 2005, 153:1187-1191.
34. Collins P., Ferguson J. Narrow-band UV (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995, 132:956-963.